For all financial filing please follow this link
07 – June – 13 Form 8-K – Current Report
06 – June – 13 Form 8-A – Registration of Certain Classes of Securities
03 – May – 13 Form 10-Q – Quarterly report
04 – April – 13 Form 8-K – Current Report
18 – March – 13 Form 8-K – Current Report
15 – March – 13 Form 8-K – Current Report
6 – March – 13 Form 10-K – Annual Report
1 – March – 13 Form 8-K – Current Report
15 – February – 13 Form 8-K – Current Report
29 – January – 13 Form 13-G – Statement of acquisition of beneficial ownership by individuals
25 – January – 13 Form 8-K – Current Report
17 – January – 13 Form S-8 – Stock and Incentive Plan
20 – December – 12 Form 8-K – Current Report
4 – December – 12 Form 8-K – Current Report
20 – November – 12 Form 8-K – Current Report
02 – November – 12 Form 10-Q – Quarterly report
24 – October – 12 Form 14-A – Proxy Statement
13 – September – 12 Form 8-K – Current Report
8 – August – 12 Form 10-Q – Quarterly report
16 – July – 12 Form 8-K – Current Report
16 – July – 12 Form 424B5 – Prospectus
16 – July – 12 Form 424B5 – Prospectus
13 – July – 12 Form 8-K – Current Report
12 – July – 12 Form 424B5 – Prospectus
10 – July – 12 Form 8-K – Current Report
9 – July – 12 Form 8-K – Current Report
12 – June – 12 Form 8-K – Current Report
23 – May – 12 Form S-8 – Stock and Incentive Plan
4 – May – 12 Form 10-Q – Quarterly report
22 – March – 12 Form 8-K – Current report
13 – February – 12 Form 8-K – Current report
9 – February – 12 Form 10-K – Annual Report
1 – February – 12 Form 8-K
13 – January – 12 Form 8-K
9 – January – 12 Form 8-K
27 – December – 11 Form 8-K
21 – December – 11 Form 8-K
8 – December – 11 Form 8-Q
7 – December – 11 Form 8-Q
1 – November – 11 Form 10-Q
28 – October – 11 Form 8-K
13 – October – 11 Form S-3 – Registration statement under Securities Act of 1933
6 – October – 11 Form 8-K
5 – October – 11 Form 8-K/A
30 – September – 11 Form S-3 – Registration statement under Securities Act of 1933
13 – September – 11 Form 8-K
22 – August – 11 Form 8-K
12 – August – 11 Form 10-Q – Quarterly report [Sections 13 or 15(d)]
7 – July – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
1 – July – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
21 – June – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC., Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8 – June – 11 Form 424B3 for AMPIO PHARMACEUTICALS, INC
25 – May – 11 Quarterly Income Statement for AMPIO PHARMACEUTICALS, INC.
20 – May – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.
13 – May – 11 Form 10-Q for AMPIO PHARMACEUTICALS, INC.
19 – April – 11 Form S-1 for Ampio Pharmaceuticals
19 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
12 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
4 – April – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities
25 – March – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Regulation FD D
25 – March – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition
16 – March – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.
18 – February – 11 Form S-4/A for Ampio Pharmaceuticals
19 – February – 11 AMPIO PHARMACEUTICALS, INC. Financials
18 – February – 11 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
15 – February – 11 Form 8-K for AMPIO PHARMACEUTICALS, INC.
07 – January – 11 Form S-4 for AMPIO PHARMACEUTICALS, INC.
07 – January – 11 Form 8-K/A for AMPIO PHARMACEUTICALS, INC.
19 – November – 10 AMPIO PHARMACEUTICALS, INC. Financials
15 – November – 10 Form 10-Q for AMPIO PHARMACEUTICALS, INC.
12 – November – 10 Form 8-K for AMPIO PHARMACEUTICALS, INC.
11 – November – 10 Form S-1 for AMPIO PHARMACEUTICALS, INC.
17 – August – 10 Form 8-K/A for AMPIO PHARMACEUTICALS, INC.
16 – August – 10 Form 8-K for AMPIO PHARMACEUTICALS, INC.
26 – May – 10 AMPIO PHARMACEUTICALS, INC. Financials
17 – May – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
14 – May – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements…
10 – May – 10 Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
27 – Apr – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi
22 – Apr – 10 Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
14 – Apr – 10 Ampio Pharmaceuticals, Inc. Appoints New Independent Director
30 – Mar – 10 AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Ar
Learn More About:
Premature Ejaculation (PE)
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.
Diabetic Retinopathy
A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness
Diabetic Nephropathy
A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis
| AMPE Stock Quote - delayed | ||
| Last | Change | |
| AMPE | 6.10 |  0.02 (0.33%) |
Ampio News
06/07/2013 | Press Release
Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
06/06/2013 | Press Release
Ampio Pharmaceuticals to List on the NYSE MKT
06/03/2013 | Press Release